Clinical Efficacy of 0.75% Boric Acid Gel in Chronic Periodontitis
Clinical Efficacy of Subgingivally Delivered 0.75% Boric Acid Gel As An Adjunct to Mechanotherapy in Chronic Periodontitis: A Randomized Controlled Clinical Trial
1 other identifier
interventional
39
1 country
1
Brief Summary
The purpose of the present study was to evaluate the effects of subgingival delivery of boric acid gel as an adjunct to scaling and root planing in chronic periodontitis (CP) patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_2
Started May 2015
Shorter than P25 for phase_2
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2015
CompletedFirst Submitted
Initial submission to the registry
September 13, 2016
CompletedFirst Posted
Study publicly available on registry
September 16, 2016
CompletedSeptember 16, 2016
September 1, 2016
5 months
September 13, 2016
September 15, 2016
Conditions
Outcome Measures
Primary Outcomes (1)
Defect depth reduction (%)
assessed in percentage
Change from baseline to 6 months
Secondary Outcomes (4)
probing depth (mm)
Change from baseline to 6 months
clinical attachment level (mm)
Change from baseline to 6 months
modified sulcus bleeding index
Change from baseline to 6 months
plaque index
Change from baseline to 6 months
Study Arms (2)
Boric acid group
ACTIVE COMPARATOROral prophylaxis followed by 0.75% boric acid drug in gel form placed in intrabony defects
Placebo group
PLACEBO COMPARATOROral prophylaxis followed by placebo gel placement in intrabony defects
Interventions
SRP followed by 0.75% boric acid placement into intrabony defect
Eligibility Criteria
You may qualify if:
- Systemically healthy with deep pockets (PD of ≥5mm or CAL ≥4mm) and vertical bone loss ≥3 mm on intraoral periapical radiographs
- Patients with ≥20 teeth with no history of periodontal therapy in the preceding 6 months nor under any antibiotic therapy
You may not qualify if:
- Patients on systemic boron therapy
- Known or suspected allergy to boron supplementation
- Patients with aggressive periodontitis
- Tobacco use in any form, smokers, alcoholics
- Immunocompromised and systemically unhealthy patients
- Pregnant or lactating females
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Unknown Facility
Bangalore, Karnataka, 560002, India
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor and Head, Dept of Periodontology
Study Record Dates
First Submitted
September 13, 2016
First Posted
September 16, 2016
Study Start
May 1, 2015
Primary Completion
October 1, 2015
Study Completion
October 1, 2015
Last Updated
September 16, 2016
Record last verified: 2016-09